Use of the Japanese health insurance claims database to assess the risk of acute pancreatitis in patients with diabetes: comparison of DPP‐4 inhibitors with other oral antidiabetic drugs

Publisher： John Wiley & Sons Inc

E-ISSN： 1463-1326|17|4|430-434

ISSN： 1462-8902

Source： DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol.17, Iss.4, 2015-04, pp. : 430-434

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide

By Dore David D.   Seeger John D.   Arnold Chan K.  

Current Medical Research and Opinion, Vol. 25, Iss. 4, 2009-04 ,pp. : 1019-1027

Informa Healthcare

Access to resources Recommend Favorite

Oral antidiabetic drug use and associated health outcomes in cancer patients

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 41, Iss. 5, 2016-10 ,pp. : 524-531

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of dipeptidyl peptidase 4 inhibitors and fracture risk compared to use of other anti‐hyperglycemic drugs

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 1053-8569, Iss. 10, 2015-10 ,pp. : 1017-1025

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of dipeptidyl peptidase 4 inhibitors and fracture risk compared to use of other anti‐hyperglycemic drugs

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 10, 2015-10 ,pp. : 1017-1025

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of oral antidiabetic drugs in the treatment of maturity‐onset diabetes of the young: A mini review

By  

DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol. 34, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite